Lidocaine Hydrochloride Solution
NDC Package 68999-871-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lidocaine Hydrochloride solution is lidocaine hydrochloride oral topical solution USP, 2% (viscous) is indicated for the production of topical anesthesia of irritated or inflamed mucous membranes of the mouth and pharynx. This formulation utilizes a solution delivery system. Marketed by Chartwell Governmental & Specialty Rx, Llc., this product is identified by NDC 68999-871 and is authorized under FDA application ANDA040708.

Identification & Billing

NDC Package Code
68999-871-24
Package Description
2 TRAY in 1 BOX / 10 CUP in 1 TRAY / 15 mL in 1 CUP (68999-871-51)
Product Code
68999-871
11-Digit Billing Format
68999087124
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lidocaine Hydrochloride
Non-Proprietary Name
Lidocaine Hydrochloride
Substance Name
Lidocaine Hydrochloride Anhydrous
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oropharyngeal - Administration directly to the mouth and pharynx.
Active Ingredient(s)
LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mL
Pharmacologic Class
Usage Information
Lidocaine hydrochloride oral topical solution USP, 2% (viscous) is indicated for the production of topical anesthesia of irritated or inflamed mucous membranes of the mouth and pharynx. It is also useful for reducing gagging during the taking of X-ray pictures and dental impressions.

Regulatory & Marketing

Labeler Name
Chartwell Governmental & Specialty Rx, Llc.
Product Type
Human Prescription Drug
FDA Application #
ANDA040708
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-27-2007
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68999-871-24 identifies a specific commercial package of 2 tray in 1 box / 10 cup in 1 tray / 15 ml in 1 cup (68999-871-51) of Lidocaine Hydrochloride, a human prescription drug labeled by Chartwell Governmental & Specialty Rx, Llc.. This solution is formulated for oropharyngeal use and contains lidocaine hydrochloride anhydrous as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chartwell Governmental & Specialty Rx, Llc. on February 27, 2007. The current certification is valid through December 31, 2027.

How is this Chartwell Governmental & Specialty Rx, Llc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68999087124. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68999-871-24
11-Digit CMS (5-4-2)
68999-0871-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.